| Dr Howard Fugate Iii, MD | |
|
111 S Front St, Harrisburg, PA 17101-2010 | |
| (717) 988-0000 | |
| (717) 782-5716 |
| Full Name | Dr Howard Fugate Iii |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 45 Years |
| Location | 111 S Front St, Harrisburg, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1093748931 | NPI | - | NPPES |
| 1514317 | Other | PA | GATEWAY |
| 000159414 | Other | PA | HIGHMARK BCBS |
| 50010087 | Other | PA | CAPITOL BC |
| 144134 | Other | PA | UNISON |
| 37121 | Other | PA | GEISINGER |
| 001048798 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | MD031608E (Pennsylvania) | Secondary |
| 207R00000X | Internal Medicine | MD031608E (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Penn Highlands Community Nurses | St marys, PA | Home health agency |
| Penn Highland Dubois | Dubois, PA | Hospital |
| Penn Highlands Elk | Saint marys, PA | Hospital |
| Entity Name | Fugate Medical Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538105002 PECOS PAC ID: 6507754314 Enrollment ID: O20040304000867 |
News Archive
According to the latest report the drop in the use of hormone replacement therapy (HRT) in mid-2002, following the results of the Women's Health Initiative study (WHI), is linked with a steep decline in new breast cancer diagnoses.
In a small study of military personnel who had suffered head trauma and had reported memory and mood problems, UCLA researchers found brain changes similar to those seen in retired football players with suspected chronic traumatic encephalopathy, a degenerative brain disease linked to repeated blows to the head.
FibroGen, Inc. today announced initiation of an open-label phase 2 study to evaluate the safety, tolerability, and efficacy of FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), in individuals with idiopathic pulmonary fibrosis (IPF), a chronic, progressive, fatal lung disease for which there are no FDA-approved therapies.
Researchers at the Johns Hopkins Bloomberg School of Public Health have developed new software that greatly improves the speed at which scientists can analyze RNA sequencing data. RNA sequencing is used to compare differences in gene expression to identify those genes that switched on or off when, for instance, a particular disease is present.
› Verified 1 days ago
| Entity Name | Charles Cole Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326161662 PECOS PAC ID: 3779487475 Enrollment ID: O20040310001269 |
News Archive
According to the latest report the drop in the use of hormone replacement therapy (HRT) in mid-2002, following the results of the Women's Health Initiative study (WHI), is linked with a steep decline in new breast cancer diagnoses.
In a small study of military personnel who had suffered head trauma and had reported memory and mood problems, UCLA researchers found brain changes similar to those seen in retired football players with suspected chronic traumatic encephalopathy, a degenerative brain disease linked to repeated blows to the head.
FibroGen, Inc. today announced initiation of an open-label phase 2 study to evaluate the safety, tolerability, and efficacy of FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), in individuals with idiopathic pulmonary fibrosis (IPF), a chronic, progressive, fatal lung disease for which there are no FDA-approved therapies.
Researchers at the Johns Hopkins Bloomberg School of Public Health have developed new software that greatly improves the speed at which scientists can analyze RNA sequencing data. RNA sequencing is used to compare differences in gene expression to identify those genes that switched on or off when, for instance, a particular disease is present.
› Verified 1 days ago
| Entity Name | Punxsutawney Area Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1265449870 PECOS PAC ID: 3375517147 Enrollment ID: O20040830000460 |
News Archive
According to the latest report the drop in the use of hormone replacement therapy (HRT) in mid-2002, following the results of the Women's Health Initiative study (WHI), is linked with a steep decline in new breast cancer diagnoses.
In a small study of military personnel who had suffered head trauma and had reported memory and mood problems, UCLA researchers found brain changes similar to those seen in retired football players with suspected chronic traumatic encephalopathy, a degenerative brain disease linked to repeated blows to the head.
FibroGen, Inc. today announced initiation of an open-label phase 2 study to evaluate the safety, tolerability, and efficacy of FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), in individuals with idiopathic pulmonary fibrosis (IPF), a chronic, progressive, fatal lung disease for which there are no FDA-approved therapies.
Researchers at the Johns Hopkins Bloomberg School of Public Health have developed new software that greatly improves the speed at which scientists can analyze RNA sequencing data. RNA sequencing is used to compare differences in gene expression to identify those genes that switched on or off when, for instance, a particular disease is present.
› Verified 1 days ago
| Entity Name | Aspire Health Concepts Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1225278922 PECOS PAC ID: 5991854168 Enrollment ID: O20090518000366 |
News Archive
According to the latest report the drop in the use of hormone replacement therapy (HRT) in mid-2002, following the results of the Women's Health Initiative study (WHI), is linked with a steep decline in new breast cancer diagnoses.
In a small study of military personnel who had suffered head trauma and had reported memory and mood problems, UCLA researchers found brain changes similar to those seen in retired football players with suspected chronic traumatic encephalopathy, a degenerative brain disease linked to repeated blows to the head.
FibroGen, Inc. today announced initiation of an open-label phase 2 study to evaluate the safety, tolerability, and efficacy of FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), in individuals with idiopathic pulmonary fibrosis (IPF), a chronic, progressive, fatal lung disease for which there are no FDA-approved therapies.
Researchers at the Johns Hopkins Bloomberg School of Public Health have developed new software that greatly improves the speed at which scientists can analyze RNA sequencing data. RNA sequencing is used to compare differences in gene expression to identify those genes that switched on or off when, for instance, a particular disease is present.
› Verified 1 days ago
| Entity Name | Clearfield-jefferson Primary Care Associates Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710233895 PECOS PAC ID: 6002064433 Enrollment ID: O20120910000652 |
News Archive
According to the latest report the drop in the use of hormone replacement therapy (HRT) in mid-2002, following the results of the Women's Health Initiative study (WHI), is linked with a steep decline in new breast cancer diagnoses.
In a small study of military personnel who had suffered head trauma and had reported memory and mood problems, UCLA researchers found brain changes similar to those seen in retired football players with suspected chronic traumatic encephalopathy, a degenerative brain disease linked to repeated blows to the head.
FibroGen, Inc. today announced initiation of an open-label phase 2 study to evaluate the safety, tolerability, and efficacy of FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), in individuals with idiopathic pulmonary fibrosis (IPF), a chronic, progressive, fatal lung disease for which there are no FDA-approved therapies.
Researchers at the Johns Hopkins Bloomberg School of Public Health have developed new software that greatly improves the speed at which scientists can analyze RNA sequencing data. RNA sequencing is used to compare differences in gene expression to identify those genes that switched on or off when, for instance, a particular disease is present.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Howard Fugate Iii, MD Po Box 348, Du Bois, PA 15801-0348 Ph: (814) 371-4443 | Dr Howard Fugate Iii, MD 111 S Front St, Harrisburg, PA 17101-2010 Ph: (717) 988-0000 |
News Archive
According to the latest report the drop in the use of hormone replacement therapy (HRT) in mid-2002, following the results of the Women's Health Initiative study (WHI), is linked with a steep decline in new breast cancer diagnoses.
In a small study of military personnel who had suffered head trauma and had reported memory and mood problems, UCLA researchers found brain changes similar to those seen in retired football players with suspected chronic traumatic encephalopathy, a degenerative brain disease linked to repeated blows to the head.
FibroGen, Inc. today announced initiation of an open-label phase 2 study to evaluate the safety, tolerability, and efficacy of FG-3019, a human monoclonal antibody against connective tissue growth factor (CTGF), in individuals with idiopathic pulmonary fibrosis (IPF), a chronic, progressive, fatal lung disease for which there are no FDA-approved therapies.
Researchers at the Johns Hopkins Bloomberg School of Public Health have developed new software that greatly improves the speed at which scientists can analyze RNA sequencing data. RNA sequencing is used to compare differences in gene expression to identify those genes that switched on or off when, for instance, a particular disease is present.
› Verified 1 days ago
Lindsey Marie Govern, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 810 Sir Thomas Ct Ste 101, Harrisburg, PA 17109 Phone: 717-614-4420 Fax: 717-614-4421 | |
Quan Tran, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 S Front St, Harrisburg, PA 17101 Phone: 717-231-8772 | |
Richard Haley Jeffries, DO Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4830 Londonderry Rd, Harrisburg, PA 17109 Phone: 717-657-2595 Fax: 717-657-3091 | |
Joanne G Gordon, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 111 S Front St, Harrisburg, PA 17101 Phone: 717-782-3380 Fax: 717-782-5716 | |
Dr. David Edward Dudick, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 111 S Front St, Internal Medicine Residency Program, Brady Hall 3, Harrisburg, PA 17101 Phone: 717-782-3131 | |
Emily Ramasra, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 111 S Front St, Harrisburg, PA 17101 Phone: 717-231-8506 | |
Mr. Siddharth Goel, M.D. Internal Medicine Medicare: Medicare Enrolled Practice Location: 205 S Front St Upmc Pinnacle, Internal Medicine Residen, Suite 3c, Harrisburg, PA 17104 Phone: 717-231-8506 Fax: 717-231-8535 |